Global Hyaluronidase Injection Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Hyaluronidase Injection Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Hyaluronidase injection is a medical procedure involving the administration of an enzyme called hyaluronidase. This enzyme breaks down hyaluronic acid, which is a natural substance found in the body and commonly used in cosmetic procedures, particularly in dermal fillers. Hyaluronic acid-based dermal fillers are used to add volume and reduce the appearance of wrinkles, lines, and scars on the skin.
Hyaluronidase Injection report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Hyaluronidase Injection market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Dermatology and Plastic Surgery are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Hyaluronidase Injection industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Hyaluronidase Injection key manufacturers include Halozyme Therapeutics, Baxter International, Amphastar Pharmaceuticals, Bausch Health, CooperSurgical Fertility, Sun Pharmaceutical Industries, STEMCELL Technologies and Daehan New Pharm, etc. Halozyme Therapeutics, Baxter International, Amphastar Pharmaceuticals are top 3 players and held % sales share in total in 2022.
Hyaluronidase Injection can be divided into Animal-derived Hyaluronidase and Synthetic Hyaluronidase, etc. Animal-derived Hyaluronidase is the mainstream product in the market, accounting for % sales share globally in 2022.
Hyaluronidase Injection is widely used in various fields, such as Dermatology and Plastic Surgery, etc. Dermatology provides greatest supports to the Hyaluronidase Injection industry development. In 2022, global % sales of Hyaluronidase Injection went into Dermatology filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Hyaluronidase Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Halozyme Therapeutics
Baxter International
Amphastar Pharmaceuticals
Bausch Health
CooperSurgical Fertility
Sun Pharmaceutical Industries
STEMCELL Technologies
Daehan New Pharm
Segment by Type
Animal-derived Hyaluronidase
Synthetic Hyaluronidase
Dermatology
Plastic Surgery
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Hyaluronidase Injection market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Hyaluronidase Injection, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Hyaluronidase Injection industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Hyaluronidase Injection in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Hyaluronidase Injection introduction, etc. Hyaluronidase Injection Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Hyaluronidase Injection market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Hyaluronidase Injection report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Hyaluronidase Injection market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Dermatology and Plastic Surgery are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Hyaluronidase Injection industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Hyaluronidase Injection key manufacturers include Halozyme Therapeutics, Baxter International, Amphastar Pharmaceuticals, Bausch Health, CooperSurgical Fertility, Sun Pharmaceutical Industries, STEMCELL Technologies and Daehan New Pharm, etc. Halozyme Therapeutics, Baxter International, Amphastar Pharmaceuticals are top 3 players and held % sales share in total in 2022.
Hyaluronidase Injection can be divided into Animal-derived Hyaluronidase and Synthetic Hyaluronidase, etc. Animal-derived Hyaluronidase is the mainstream product in the market, accounting for % sales share globally in 2022.
Hyaluronidase Injection is widely used in various fields, such as Dermatology and Plastic Surgery, etc. Dermatology provides greatest supports to the Hyaluronidase Injection industry development. In 2022, global % sales of Hyaluronidase Injection went into Dermatology filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Hyaluronidase Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Halozyme Therapeutics
Baxter International
Amphastar Pharmaceuticals
Bausch Health
CooperSurgical Fertility
Sun Pharmaceutical Industries
STEMCELL Technologies
Daehan New Pharm
Segment by Type
Animal-derived Hyaluronidase
Synthetic Hyaluronidase
Segment by Application
Dermatology
Plastic Surgery
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Hyaluronidase Injection market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Hyaluronidase Injection, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Hyaluronidase Injection industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Hyaluronidase Injection in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Hyaluronidase Injection introduction, etc. Hyaluronidase Injection Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Hyaluronidase Injection market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices